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Abstract The effect of heparin (HE) on the susceptibility of 
human low-density lipoprotein (LDL) to Cu2+-induced oxidation 
was investigated by monitoring conjugated diene formation. HE 
did not modify the maximum formation of conjugated iene, but 
increased markedly the lag phase. The plot of change in oxidation 
rate vs. time showed that the absolute value of Vmax was dependent 
on Cu 2÷ concentration and that HE increased the time necessary 
to reach Vma x. The value of constant K (the Cu 2÷ concentration 
producing a fi~g of twice the minimum value) increased in the 
presence of HE, whereas the value of tmi. (the time theoretically 
required for LDL oxidation at an infinite Cu 2÷ concentration) was 
not substantially affected. These results indicate that HE might 
play a protective antioxidant effect on LDL, probably affecting 
both the structural properties of the particle and the amount of 
Cu 2+ available for the oxidation. 
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1. Introduction 
The lipid deposition in arterial wall by low-density lipopro- 
tein (LDL) is a critical point in the development of atheroscle- 
rotic degeneration. Oxidative modifications of LDL are likely 
to increase its atherogenic potential, since macrophages and 
smooth muscle cells in culture avidly accumulate oxidized LDL 
quite independently from intracellular cholesterol level, leading 
to foam cell formation [1,2]. Moreover, oxidized LDL may 
promote thrombosis, acting on both endothelial cells and plate- 
lets [2]. 
LDL oxidation probably occurs in the arterial wall, where 
it is excluded from the antioxidant activity of plasma [1,2]. 
Moreover, atherosclerotic arterial wall contains increased lev- 
els of copper and iron ions, which induce LDL oxidation [3]. 
In this compartment, LDL may interact also with proteogly- 
cans (PGs), forming complexes that are taken up avidly by 
macrophages [4,5]. The interaction of LDL with hexuronate- 
containing sulphated glycosaminoglycans was recently shown 
to modify the structural properties of the particle, heparin (HE) 
being particularly effective [6]. 
On this basis, we studied whether the susceptibility of LDL 
to oxidation might also be affected by HE, which was found 
to decrease lipid-free radical peroxidation [7]. 
As experimental model, we used the highly reproducible 
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LDL oxidation mediated by Cu 2+ [8,9]. In this model, the lag 
time of LDL oxidation decreases with increasing Cu z+ level, 
according to a relationship described by an equation formally 
similar to that of Michaelis and Menten for enzyme kinetics 
[lO]. 
2. Materials and methods 
Human LDL was prepared from fresh pooled EDTA plasma of 
normolipemic donors by ultracentrifugation using a single-step discon- 
tinuous gradient in a Beckman SW 41 rotor at 38,000 rpm for 20 h at 
10°C, according to Dieber et al. [11] with minor modifications. LDL 
was collected as the fraction floating at a density of 1.019 to 1.063 g/ml 
and used within 1 week from the isolation. Its mean composition was 
as follows: 26.0 + 1.3% proteins, 15.8 _+ 0.8% phospholipids, 
48.7 + 2.4% total cholesterol, 9.5 + 0.5% triglycerides. 
Protein concentration was determined according to Smith et al. [12]. 
Total cholesterol, phospholipid and triglyceride contents were assayed 
by standard enzymatic methods (Boehringer Mannheim). 
The mean diameter of LDL resulted of 20 nm, as determined by quasi 
elastic laser light scattering [13] using a BI 90 particle sizer (Brookhaven 
Instrument Corporation, Holstville, NY), equipped with a laser source 
at an excitation wavelength of 632.8 nm. 
Before oxidation, LDL was desalted by exhaustive dialysis against 
10 mM phosphate-buffered saline (PBS), pH 7.4, at 4°C in the dark. 
Samples of LDL corresponding to 80/.tg cholesterol/ml were then oxi- 
dized with 0.9, 1.8 and 3.6/zM CuSO4. These concentrations are in the 
range originally used by Gieseg and Esterbauer [10] and in the same 
order of magnitude as those described in atherosclerotic plaques [3]. 
The oxidation was performed in PBS at 30°C, in the absence and in the 
presence of HE (varying from 150 to 750/lg/ml, corresponding to
72 362/~g/ml of hexuronate) (Sigma). The oxidation was monitored 
continuously by measuring the increase in absorbance at234 nm due 
to the formation of conjugated CC double bonds [14]. 
The water used to make up reagents was purified from inorganic and 
organic contaminants by an Elga-Stat UHQ apparatus (Wycombe 
Bucks, UK). All other reagents were of analytical grade. 
3. Results 
The kinetics of Cu2+-induced oxidation of human LDL were 
followed by determining the curves of diene vs. time profile. In 
the absence of HE, the decrease of Cu 2+ concentration i the 
reaction mixture was coupled with an increase of the value of 
lag time (qag), determined graphically by the intercept of the 
tangents to the slow and fast increase of the diene absorption 
[10] (Fig. 1, open circles). In the absence of HE, the values of 
fi~g were as follows: 61 min at 3.6/~M CuSO4; 84 min at 1,8/IM 
CuSO4 and 110 min at 0.9/aM CuSO4. The presence of HE in 
the incubation mixture (Fig. 1, black circles) did not modify the 
maximum formation of conjugated dienes, but increased signif- 
icantly tjag. This increase was progressively higher at lower Cu 2+ 
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F'i~_. 1. Effect of heparin on the kinetic of Cu2+-induced oxidation of 
human LDL. Human LDL (80/zg/ml as total cholesterol) in 10 mM 
PB ¢~ was incubated with different CuSO4 concentrations (3.6/.tM: a; 1.8 
///~: b; 0.9 pM: c) in the absence (o-o) and in the presence (o-o) of 150 
pgml HE. The formation of u.v.-absorbing conjugated ienes was 
followed recording the increase in 234 nm absorbance in 1-em cuvette 
at ~0°C. The initial absorbance was subtracted from all data. The value 
of ',,g (in the absence of HE: ~; in the presence of 150 pg/ml HE: ~) 
wa ~ determined graphically as reported insection 2. Similar esults were 
ob~ ained in three independent experiments, using different LDL prepa- 
rat,ons. 
concentrations. Preliminary experiments showed that HE was 
eft ective above the concentration of 150/zg/ml. In the presence 
of 150/ag/ml HE,/lag values were: 78, 116, 185 min at 3.6, 1.8, 
0. '' pM Cu 2+, respectively. When higher amounts of HE were 
en ployed, the value of Gg increased very markedly and in the 
pr,:sence of the lowest Cu 2+ concentrations the propagation 
phase of lipid peroxidation was even incomplete after 350 min 
imubation, preventing the determination of tlag (data not 
shown), 
Fhe first derivative of diene formation vs. time profiles was 
then calculated to obtain the change of oxidation rates as a 
function of time. The calculation was performed by the method 
of forward difference numerical derivation. These data are re- 
p(,rted in Fig. 2, showing that in the absence of HE (open 
cfi cles) the time required to reach the maximum velocity (Vm~ 0
of lipid peroxidation i creased constantly with decreasing Cu 2+ 
concentration (77, 103, 129 rain at 3.6, 1.8, 0.9 pM CuSO4, 
respectively). 
Fhe presence of 150 pg/ml HE in the incubation mixture (Fig. 
2, black circles) delayed the reaching of Vm,x and this delay was 
higher at lower Cu 2+ concentrations. Under these experimental 
conditions, Vmax was reached after 89, 133,205 rain at 3.6, 1.8, 
0.9 pM CuSQ, respectively. 
The decrease of Cu 2+ concentration was coupled with a de- 
crease of Vmax value both in the absence and in the presence of 
HE. Moreover, the presence of HE decreased the value of Vmax 
only when the highest Cu 2+ concentration (3.6//M) was em- 
ployed (Fig. 2a). Kinetic parameters were further elaborated 
according to Gieseg and Esterbauer [10], who recently showed 
that the relationship between Gg and Cu 2+ concentration can 
be quantitatively described by the following equation which has 
the same functional form as the Michaelis and Menten equa- 
tion: 
1 1 Cu 2+ 
tla~ tmi. K+[Cu 2+] 
The values of K (the copper concentration producing a tlag 
of twice the minimum value) and tlag minimum (trnin, the time 
theoretically required for LDL oxidation at an infinite Cu 2+ 
concentration) were graphically determined from the double 
reciprocal plot of llag VS. l /Cu 2+. The value of K was given by 
the negative reciprocal of the x-axis intercept and the value of 
tmi,, by the ),-axis intercept [10]. K value resulted 1.2/~M Cu 2+ 
in the absence of HE and 2.5 tiM Cu 2+ in the presence of 150 
/.tg/ml HE. On the contrary, the value of tm~n was not substan- 
tially affected by the presence of HE, resulting always in 50 min. 
4. Discussion 
This study reports evidence that HE shows a significant pro- 
tective effect on CuZ+-induced oxidation of human LDL. The 
presence of HE in the reaction mixture increased both the lag 
phase and the time required to reach Vm,x of lipid oxidation. 
This effect was more marked with decreasing Cu 2+ concentra- 
tion. 
The determination of tmin gave the same result both in the 
absence and in the presence of HE indicating that at an infinite 
Cu 2+ concentration HE does not affect the length of lag phase. 
On this basis, it might be suggested that the effect of HE on the 
lag phase is founded on a competitive mechanism, since the 
protective antioxidant effect of HE is removed by the increase 
of Cu 2+ concentration i the reaction mixture. 
As recently shown by Gieseg and Esterbauer [10], the de- 
crease of Cu > concentration was coupled with a decrease of 
Vmax of conjugated diene formation, which is an index 
of the propagation phase and depends only on the lipid compo- 
nent of LDL. Under our experimental conditions, the addition 
of HE reduced the value of Vm:,x only in the presence of the 
highest Cu 2+ concentration. It was recently demonstrated that 
the interaction of HE with LDL induced a significant decrease 
of the microviscosity of LDL hydrophobic region, affecting 
also the thermotropic properties of both protein and lipid com- 
ponents [6]. These results indicate that the interaction of LDL 
with HE is likely to modify the structural properties of the 
particle. On this basis, we suggest that the structural modifica- 
tions induced by HE on LDL might allow a propagation rate 
of Cu2+-mediated oxidation which cannot reach the corre- 
sponding value of native LDL. This phenomenon is evident at 
the highest Cu 2+ concentration, which corresponds to the high- 
est value of V,,~,x. 
However. the protective ffect of HE on LDL oxidation is 
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Fig. 2. Change of rates of Cu2+-induced LDL oxidation as a function 
of time. The values were obtained etermining the first derivative of 
diene formation vs. time profiles reported in Fig. 1. Control LDL, 
incubated in the presence of CuSO4 only: o-©; LDL incubated in the 
presence ofboth CuSO4 and 150/zg/ml HE: e-e. CuSO4 concentration: 
3.6/aM: a; 1.8/aM: b; 0.9/aM: c. The data were smoothed by a moving 
average calculation (average change in 234 nm absorption over 10 rain) 
to reduce the noise in the plot. 
not limited to the structural modifications ofthe particle, which 
probably involves a different accessibility of the lipid compo- 
nent to the oxidative process. HE is likely to affect also the 
amount of Cu 2+ available for the oxidation, as suggested by the 
marked increase of the constant K in the presence of HE. The 
value of K indicates the Cu 2+ concentration at which half of the 
pro-oxidative Cu2+-binding sites are occupied [10]. Under our 
experimental conditions, LDL are employed at a concentration 
of 80 pg cholesterol/ml equal to 0.1 pM, according to Gieseg 
and Esterbauer [10]; therefore, the rate of initiation is half the 
maximum at 14 Cu 2÷ ions/LDL particle in the absence of HE. 
The addition of HE requires 25 Cu z+ ions/LDL to reach the 
same oxidative ffect. This phenomenon could be explained on 
the basis of two different mechanisms: (1) a partial sequestra- 
tion of Cu 2÷ by the polyanion chain of HE; (2) the possible 
change in the ability of LDL to bind Cu 2+, due to the structural 
modification of the particle following the interaction with HE. 
HE was shown to inhibit Fe2+-catalyzed peroxidation of 7/- 
linolenic acid [7]. Our study emphasizes that the antioxidant 
effect of HE protects not only a free fatty acid, but also a 
biological structure, such as human LDL against Cu2+-induced 
oxidation. This model of oxidation was demonstrated to pro- 
duce LDL sharing many structural and functional properties 
with LDL oxidized by cells [15] or extracted from atheroscle- 
rotic plaques [16]. Moreover, it should be reminded that Cu 2÷ 
ions are contained inaortic wall and increase in atherosclerotic 
plaques [3], where they may contribute to the development of
the lesion by oxidative stress. On this basis, we suggest that HE 
(and probably other glycosaminoglycans occurring in native 
PGs) might play a regulatory role in the process of LDL oxida- 
tion in vivo, which may change the metabolic fate of the parti- 
cle, increasing its atherogenic potential [1,2]. 
HE is largely employed in anticlotting treatment even for 
relatively long periods of time. Our paper raises the question 
whether HE could also play an antithrombotic role, decreasing 
the formation of oxidized LDL which are known to exhibit a 
prothrombotic a tivity [1,2]. 
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